Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
1 other identifier
interventional
64
1 country
1
Brief Summary
The aim of the study is to evaluate an objective, non-invasive optical device able to quantify, without eye contact, the width of the irido-corneal angle and to better identify cases of narrow angle or angle closure that may be prevented with relatively simple treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2024
CompletedFirst Submitted
Initial submission to the registry
February 15, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 7, 2025
February 1, 2025
5 months
February 15, 2024
March 5, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Agreement between the automatic Narrow Anterior Chamber Angle Estimator grading of peripheral anterior chamber width with clinical grading as performed by Van Herick (VH) test at slit lamp
The angle is graded by the NACA estimator as the ratio between the peripheral anterior chamber depth and limbal-corneal thickness, as observed in the slit lamp by the microscope section. A high-resolution camera will synchronously acquire the images to generate the irido-corneal angle grade that will be classified in four grades following the VH classification. The standard VH grading scale will be: * 1 = space between iris and corneal endothelium of \<¼ corneal thickness (angle closure likely), * 2 = space between iris and corneal endothelium of ¼ corneal thickness (angle closure possible), * 3 = space between iris and corneal endothelium of ½ corneal thickness (angle closure unlikely), * 4 = space between iris and corneal endothelium ≥ 1 (corneal thickness angle closure very unlikely).
12 months
Agreement between the automatic Narrow Anterior Chamber Angle Estimator grading of peripheral anterior chamber width with clinical grading as performed by gonioscopy.
The angle will be graded for each quadrant at gonioscopy using the modified Shaffer grading system, by which each grade corresponds to the visibility of the different angle structures.
12 months
Secondary Outcomes (2)
Reproducibility (intra-session) and repeatability (inter-session) of the peripheral anterior chamber width (PACW) evaluation by the Narrow Anterior Chamber Angle Estimator
12 months
Sensitivity and specificity of NACA Estimator grading of PACW in detecting primary angle closure suspects as classified by clinical gonioscopy.
12 months
Interventions
Grading of peripheral anterior chamber width with the Narrow Anterior Chamber Angle (NACA) Estimator
Eligibility Criteria
You may qualify if:
- Willingness to participate and ability to understand and sign an informed consent.
- years of age or older.
- Healthy subjects, patients with PACS or angle closure as defined by the EGS Guidelines.
- The right eye will be included in the study for all patients, unless a clinical contraindication to the examination is present.
You may not qualify if:
- Inability to understand and sign an informed consent.
- Any prior ocular surgery or laser treatment with the potential to alter the natural anatomy of the anterior segment of the eye.
- Corneal or conjunctival abnormalities that preclude an adequate view of the anterior chamber.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Fondazione GB Bietti
Roma, Italy, 00184, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2024
First Posted
February 26, 2024
Study Start
September 5, 2023
Primary Completion
January 20, 2024
Study Completion
December 31, 2024
Last Updated
March 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share